1. Home
  2. PTCT vs PATH Comparison

PTCT vs PATH Comparison

Compare PTCT & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$71.41

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Logo UiPath Inc.

PATH

UiPath Inc.

HOLD

Current Price

$18.53

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
PATH
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
5.6B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
PTCT
PATH
Price
$71.41
$18.53
Analyst Decision
Buy
Hold
Analyst Count
17
17
Target Price
$80.65
$14.41
AVG Volume (30 Days)
794.0K
65.6M
Earning Date
05-07-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
264.48
500.00
EPS
0.90
0.04
Revenue
$264,734,000.00
$1,610,572,000.00
Revenue This Year
N/A
$11.82
Revenue Next Year
$17.70
$8.50
P/E Ratio
$79.77
$447.04
Revenue Growth
36.19
12.65
52 Week Low
$57.08
$9.20
52 Week High
$90.87
$19.84

Technical Indicators

Market Signals
Indicator
PTCT
PATH
Relative Strength Index (RSI) 45.98 72.75
Support Level $67.57 $9.69
Resistance Level $73.86 $19.84
Average True Range (ATR) 2.00 0.72
MACD 0.17 0.07
Stochastic Oscillator 54.41 92.56

Price Performance

Historical Comparison
PTCT
PATH

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.

Share on Social Networks: